The RestoreXL™ is manufactured in the United States by PathRight Medical, located in Orem, Utah.
The RestoreXL™ was designed to recover lost penis length following a history of radical prostatectomy or Peyronie's disease.
Unlike the standard RestoreX™, it only develops axial traction on the penis, the force of which, between 2.5 and 3 Kg., is sufficient to overcome atrophy and improve the quality of erections.
✓ RestoreXL™ was evaluated in patients who had undergone radical prostatectomy resulting in penile shortening¹ᵇ:
- 94% of patients recovered 1.6 cm of penis length after a 6-month treatment that started 1 month after the procedure.
- 73% of patients experienced an improvement in erectile function.
- No adverse effects were reported during or after the clinical studies.
✓ The clinical study concerning Peyronie's disease shows an increase in penis length of between 2 and 2.2 cm after 6 months of treatment 1ᵃ.
✓ There are no clinical studies on RestoreXL™ for increasing the length of small penises, and we refrain from providing information that has not been clinically validated. We know that RestoreXL™ allows for stretching, but it does not provide lengthening, as this has not been clinically proven. Only surgery can achieve a very substantial increase in penis length.
Cough & al.: Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial /AUA - The Journal of Urology – August 2021, Volume 206, Issue 2, Page: 416-426
Efficacy of a new penile traction device in improving penis length and erectile function after prostatectomy: Results of a prospective randomized single-center study.
Zganjar & al.: Efficacy of RestoreX™ Post Prostatectomy: Open-label Phase of a Randomized, Controlled Trial /BJU International - 2023 Aug;132(2):217-226
Efficacy of RestoreX™ in post-prostatectomy: 1st open-access phase of a randomized clinical trial with a control group.
Wolters Kluwer: New device helps restore penile length and sexual function after prostate cancer surgery / The journal of Urology - June 1, 2021
The RestoreXL™ is marketed by Med'Arte, a French company specializing in the sale of medical devices for Urology to healthcare facilities.
